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T o further evaluate the nature of the HLA association 
with psoriasis. HLA haplotypes of 60 patients with 
type I (early onset. positive family history) and 30 
patients with type II (late onset. no family history) 
psoriasis were investigated by polymerase chain re-
action sequence-specific oligonucleotide hybridiza-
tion (HLA class II) and serology (HLA class I). Ethni-
cally matched blood donors (146) served as controls. 
In type I. but not type II psoriasis. the Caucasian HLA 
extended haplotype (EH) Cw6-B57-DRB1*0701-
DQA1*0201-DQB1 *0303 named according to the B 
allele EH-5 7.1 was highly significantly overrepre-
sented (Pcor. = 0.00021). This particular EH was 
present in 35% of type I psoriatics but only 2% of 
controls. EH-57.1 + individuals therefore carry a 26 
T he familial nature o f psoriasis, w hich is a common cutaneous disease affecting alm ost 2% o f Caucasians, has long been recognized . The considerabl e influ-ence of he red ity o n the develo pment of psoriasis is dem o nstrated by the fo llo win g. 1) Approximately 
one- third o f psoriatics ha ve at least o ne imJ1lediate re lati ve with 
psoriasis (Farbe r cl II I, 1968) . 2) Indiv iduals ha ving a m onozygotic 
twin wi th psoriasis run a 70% risk of developing th e disease 
(Brandrup eI ai, 1978) . 
In parall e l to the re lationship be tween the possess ion of parti cular 
HLA alle les and development o f o ther autoiml11un e disease (N e-
porn el ai , 1991) , early o nse t of psoriasis is kn own to be associated 
with HLA class [ antigens (HLA-Cw6, -D13, -B17) (Russel et ai, 
1972; White ct ai, 1972; Svej gaard ct ai , 1974; Brenner ct ai , 1978 ) 
and cl ass II (HLA- DR7) all eles (T iw ari et ai, '1982). Subsequentl y, 
two types of psorias is that diffe r in age of onset and he ritabili ty have 
been defin ed (Henseler and C hristophe l'S, 1985 ; C III'istophers and 
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times higher risk of d eveloping type I psoriasis than 
individuals who are EH-57.1-nega tive. Furthe r anal-
ysis of individual HLA alleles revealed that within 
EH-57 . 1. HLA class I antigens (Cw6-B57) were asso-
ciated to a much higher extent with type I psoriasis 
than the HLA class II alleles (DRB1 *0701-
DQA1*0201-DQB1*0303). Pedigree analysis of three 
multiply affected families over thre e generations re-
vealed a cosegregation of disease with EH-57.1. 
These results strongly suggest that a gene for famil-
ial psoriasis is associated with the class I side of 
the extended haplotype Cw6-B57-DRB1 ~' 0701-
DQA1*0201-DQB1"'0303. Kq IVonts: Iristocompatibility 
aJrtigerrs/disease sllsceptibilit)'/poi}"nerase chain reaction/all-
toimmllne disease. ] I,,,,est D emratoi 106:711-7 14, 1996 
H ensele r, 1989). According to these fi ndings. type I run s in 
fa milies, has an early onset, and is associated with I-ILA-Cw6, -B13 
and -D5 7. Type II occurs spo radica ll y. is characteri zed by a late 
o nse t, and show s onl y w eak corre lation with HLA-Cw2 and -B27. 
H LA m olecules are gene products of the m ajor histocompatibili ty 
complex (MHC) loca ted on the sho rr arm of chrom osom e 6 . T he 
genes m ost distant fi'om the centro m ere arc th ose that encode the 
class 1 m olecul es A . C, and D w hil e the genes closer to the 
centro mere encode the HLA class 11 m olecules HLA - DR, - DQ. 
and -DP. HLA c1 .1SS III is located be tween HLA c lass [ and class II 
and constitutes seve ral genes including those fo r th e complemen t 
components and tumor necrosis facto r (Trowsda le ct ai, 1991); 
however. numero us oth e r genes that have no t yet been character-
ized also exist in the H LA complex (Sargent et ai, 1989; Hanson cl 
al, 199 '1) . 
It has long been kn own that in an un se lec ted population, alleles 
at different H LA loci are in lin kage disequilibrium , i.e., specific 
combina tions Occur m Ore o r less frequently than expected by 
chance. The groups of D awkins and Yunis (D egli-Eposti CI ai, 1992; 
Awdeh ct ai, 1983) revealed the existen ce o f bas ic linkage disequi-
libriu!11 sets ca lled ancestral o r extended haplotypes. £n fa mily 
studies . ancestral haplotypes and recombin ati ons between limi ted 
pairs of them consti tute alm ost 90'!!', of aU MH C hapl o types and 
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account for almost all of the observed linkage disequilibria 
(Dawkins et ai, 1989). 
In a previous study, we fo und an oven'epresentation of the HLA 
class r antigens Cw6 and B57 and the HLA class IJ alJ eJes 
DRBl *0701, DQA1 *0201, and DQB1 *0303 in type I psoriasis 
(Schmitt-Egenolf el ai, 1.993), corroborating preliminary results 
from DegJi-Eposti el al (1992). Ln this study, we lInOllyzed by m eans 
of serology and hybridization with specific oligonucleotides haplo-
types extending from HLA-B to -DQBl of 1) additional type I as 
well as type II psoriatics, 2) ethnically matched controls, 3Jld 3) 
three famili es with a high in cidence of type I psoriasis. 
In summary, this study revealed that type I psoriasis is associated 
w ith the HLA class T side of the extended haplotype Cw6-BS7-
DRBl "0701-DQAl ' 0201-DQB1 ' 0303, whjch is nnm ed accord-
ing to the B allele, EH-57 .1 (Degli-Eposti et ai, 1992) . 
M ATERlALS AND METH ODS 
Subj ects For the population stud y, the patient group comprised 90 
Ca ucasians ildmitted to tbe Dcpartment of Dermatology, University of 
Ulm , and the Fachklinik Bad 13entheim, Bad 13ell th eim, Gerlllll ny, ,111 with 
chronic stable p soriasis. Sixty C<lses with a positive f.1mi ly hi.,tory and an 
onset age of less than 30 years werc referred to as typc I p sori atics. T hirty 
patients with a ncgative family history and an onset of diseasc later than age 
40 were referred to as type II psoriatics. Psoriatics with onse t at agc 30 to 
40 can b e found in bo th groups in an equal proportion (Henseler and 
Christophers, 1985) and were thcrefore excluded from the stud y. One 
hundred forty-six ethnica lly matched hlood donors served as controls. 
Informed consent was o btained from all subjects. C lass I antigen analysis 
was performed sero logica ll y, 'Illd expression of HLA class II . alle les was 
examined by polym erase ch ai n reaction sequence-specific o ligonucleotide 
hybridization . For the family study, three multipl y ,dlcctcd f.1mili es with a 
tota l of 14 cascs of chronic stable p soriasis (onset < 30 years) and 31 
una[ected rehltives Were recruited from the population study gro up. 
Seve rity of disease was estimated as petcent of body surfilce affected: 1) 
< 1'V. ,; 2) 1-10%: 3) 10-20%; 4) 30-40%; 5) > 40%. Because of the relapsing 
nature and drug dependency of psoriasis, case historics rather th an present 
status were considered for disease grading. Family and pcrsonal histories 
were obtained from each subject. Fami lies with both a patern,,1 and matern al 
history of psoriasis were excluded. 
HLA Typing Analysis for typin g class I antigens was pcrformed by 
standard serological methods (Terasaki cf ai, 1986). 
Polym erase chain rcaction was carried for typing class Il all eles out as 
previously described (Eierman er (fl , 1991) with the following modifI cations. 
Fot generic amplification of 286-bp fragments of ORB second cxon AMP1 
5 '-TTCGCCGCTGCACTGTGAAGCTCTC and AMP3 5 ' -CCGAATC-
CTTCGTGTCCCCACAG CCG were used 'IS primers . After 30 cycles of 
PCR. with 2.5 unils ofTherl11os aquaticus DNA polymerase (Cetus/Perkin 
Elmer, Norwalk , CT) products were checked for single band 'lJllplimers on 
ethidium bromide-stained mil1igels. After heat denaturation of the DNA, 
aliquots were spotted m anually on nylon membranes and immobili zed by 
ultraviolet irradiation (120 mJ , Stnlt.aUnker, Stratagene). O Ugonucleotides 
were constructed on an Applied I3iosystcms 380B DNA synthesizer and 
have been described elsewhere (Ba llas cf (f l, 1992). Each scquence- specifi c 
o ligonucleotide was 3' -end labeled with dideoxy-digoxigcnin by termin,,1 
po lynucleotidyl transferase (Boehringer Mannhcim, Indianapo li s, IN). Fil-
ters were l'rehybrid ized in 3 M tetral11ethylammonium chloride, 100 ILg/ml 
salmon sperm DNA, 50 mM T ris-HC), 0.1% sodium dodeeyl sulfate, 5X 
Denh,trdt's solution and 2 mM cthylcnedimninetetraacetic acid for 2 h , after 
which 3-5 pM of labeled sequence-specific oligonucleotide probes were 
added and hybridized for at least 3 h. After removal of the hybridization 
so lution , fi lters were washed under str-ingcnt conditions in 3M tctramcth-
yl;lmmonillm chloride, 50 mM T ris-J-lC I, and 0.2";', sodium dodecyl sul fate . 
Hybridized o ligonucleotides were detect.cd using a digoxygenin-specifi c 
monoclonal 'II1tibody conjugated [ 0 alk,,[ine phosphatase (Boehringer 
Mannheim) and binding waS visualized with all enhanced chemilumines-
cence system (Amcrsham) . 
Statistical Evaluation Absolute n umbers of cascs positive for the allele 
or alleles undcr in vcstigation were determined and 1) di vided by the number 
of Cases (phenotype frequency) and 2) used to calculate XZ likelihood ratios. In 
cascs where I' < 0.01 the observed difference was scorcd as statistically 
significant and only in cases with p < 0.001, the observed difference was rated 
as statisticall y highly signi.ficanc as reccntl y recommended (Svejgaard and Ryder 
1994). The p-v"lue", were corrected by the number o f comparisons made 
according to Dunn (1961), i.e., nllmber of HLA <I llcle", under in vestigation 
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F igure 1. EH-S7,l-positive indiv iduals carry a 26 times elevated 
risk of developing type J psoriasis, HLA class I alltigens were analyzed 
by swndard sero logical methods, and HLA class [l all eles were typed by 
PCR-SSO. Absolute numbers of cases positive for the a ll ele o r a lle les under 
investigation were determined alld used to c.1Jcul ate phenotype frequencies 
as well as ;(2 likelihood rarios. T he p- va lues were corrected accord ing to 
13ol1fcrroni . Phenotype-frequencies (Pf) of the single HLA class I and U 
all eles within EH-S7.1 and of £ H-57.1 itself arc shown . Contro ls (operl 
CO /II11I11 S) are compared with type I and type II psoriasis (so /id CO/II I11 /1S). 
Significantly overrepresented (p«><. < 0 .01) and highl y sign ifi cantly over-
represented all eles (Peo, .. < 0.001) are dcnoted by * and " , respectively. RR 
va lues werc computed <lccording to Woolf (1955) and arc demonstrated by 
b1ac!, dia lll ollll ... 
(107) X paticnt subb'l'OUpS (2) = 2'14. The relative risks (RR) were calculated 
according to Woolf (1955). If critical entries were zero, Haldane's (1956) 
modification ofWoolfs forlllula w"s uscd. 
R .ESULTS 
T ype I Psoriasis Is Associated with the Class I Side of 
EH-57,l T he Ca ucasian extended haplotype EH- S7.1 (Cw6-
BS7-DRBl ' 0701-DQA 1 "020J -DQBl *0303) was high.1y signifi-
cantly overrep resented (35% vs 2% in the control group; p = 
0.000001; P co ,'. = 0.00021; R..R. = 26) even after th e correction of 
p. A ll class II alleles contained in EH- S7.1 were highly significantly 
(DQBl "' 0303) or significantly (DRB1 *0701, DQAl *0201) over-
represented before the correction of p. DRBI "0701 and 
DQA 1 *0201 (58% vs 33%; p = 0.0076; P cor. = 1.62) were not 
significantly overreprcsented after the correction of p. Olll)' 
DQBl *0303 (35% vs 9'0,; p = 0.00001; P eo r . = 0.0021) rcmained 
significantly overrep resented. T h e HLA class I alleles C w6 (82% vs 
21%; p = 0.000001; P cor. = 0.00021) and B57 (53'X) vs 4%; P = 
0.000001; P eo r . = 0.00(21) were high ly significantly overrepre-
sented after the correction o f p (Fig 1). 
The different impact of class I and class n all eles on psoriasis was 
further demonstrated by indi vid uals positi ve for the class I antigens 
of EH-57.1 (Cw6-B57) bu t lacking the class II alleles of this EH 
(DltBl *0701-DQAl "0201-DQBl *0303 ) (henceforth refen'ed to 
as class I side positive) who were significantly ovelTepresented in 
type I psoriatics compnred with the control gro up (12% vs 2%' p '" 
0.0060; R.R = 6.30). In contr;1st, individuals positive for the class n 
alleles of EH-57 .1 but not possessing the HLA class I alleles 
(hencefo rth referred to as class II side positive) represented 5% of 
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Figure 2. The HLA class I, but not the class II side of EH-57.1, 
confers susceptibility to type I psoriasis. Phenotype fi·cql1cncy (Pf) 
of haplotypes containing the class I antigens of EI-I-S7. 1 (Cw6-U 57) 
but Itlcking thc class II alleles of this EI-I (DRJ3l*070 1-DQAl ' 020 1-
DQB1*0303) (referred to as the class I side) and of haplotypes pos itive for 
the class II alleles of EI-I-57. 1 in the absence of its I-ILA-class I alleles 
(referred to as the class II side) in controls (OI'CIi WIIl"IIIS) and type I psoriasis 
(solid wl",,",s). 
the control group bur were not present in typ e I psoriatics (I' = 
0.0265; RR. = 0.15) (Fig 2). 
Analysis of only the highly significantly elevated alle les , HLA-
B57 and HLA-Cw6, revealed that in controls as well as type I 
psoriatics all HLA-1357 + subjects were also I-ILA-Cw6+. In type I 
psoria ti cs lacking HLA- B57 (n = 28) the antigen I-ILA-Cw6 was 
still present in 17 cases and therefo re highl y significantly overrep-
resented (61 % vs 21%; I' = 0.00005). 
HLA alleles not contained in EH-57. 1 were not signifi cantl y 
overrepresented. T he antigens HLA-B44 (12'X, vs 29'Y, ,; p = 0.0058; 
Pcor. = 1.26) and -B51 (2°/., vs 14'10; p = 0.0020; Pc, ,, .. = 0.42) were 
significantly underrepresen ted before but not after the correc tion of 
p. 
Type II Psoriasis Showed No Significant HLA-Association 
The EH-57.1 was presen t in 3% of type II psoriatics and only 2% of 
con trols. The HLA alle les All (27% vs 7'10,; p = 0.0036; Pco, .. = 
0.77), DRBl *1502 (7% vs 0%; p = 0.0073; Pcu, .. = 1.56) and 
DQBl "060l (7% vs 0%; p = 0.0073; Peo, .. = 1.56) showed a 
significantly positive association before but not afte r the correc tion 
of p. As in type I psoria tics the alle le l-lLA-1344 was signifi cantl y 
underrepresented (7% vs 29%; p = 0.0046; Pc",. = 0.98) before but 
not a fte r the correction of p (Fig 1). 
The Analysis of Three Multiply Affected Families Carrying 
EH-57.1 Revealed a Cosegregatioll ofEH-57.1 with Marked 
Disease The examination of these families with a tota l of14 cases 
of chronic stable psori as is revealed a cosegregation of EI-I-57. 1 with 
marked disease (> 1% body surf.1ce aWected). Minimall y affected 
fam ily members «1 % body surf.1ce affected) d id n ot fundamenta lly 
share any HLA all ele with afFected fami ly m embers (famil y B). T he 
una ffected children in generation III were all yo un ger than 25 
(mean 17 .4; median 16), thus , a late r m anifestation of type I 
psoriasis in this generation cannot be excl uded . In all fa milies tested 
no individual of gene rati on I was sti ll li ving and I-ILA-typing could 
not be perfo rmed . Individuals in genera tion II are referred to as 
"gran dparents. " 
In fa mily A, th e EI-I-57.1 + grandfather who had a positive f.ulli ly 
history was minimally affected «1 % body surf.1Ce). [n the second 
generation two out of four siblin gs were EI-I-5 7.1 + and bo th were 
affec ted, one child was EH-57 .1 - and healthy and one child WaS 
EH-57.1 - and minimall y affected «1% body slIrf.lce). T he g rand-
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f;lthe r 's sister was EH-57. 1 - . and ne ithe r she nor her three 
daughters were "ffected. 
In f.llnil y D, the EI-I-57.1 + grandf.1the r who had a f;ul1 ily history 
of psoriasis was affected. All five children were E I-I-57. 1 +, but on ly 
one was afFected. T he HLA hap lotype that this child inherited from 
he r moth er (Cw7-B7-DHJ31 "' 1501 -DQA 1 *01 02-DQB1 *0602) 
differed in the I-ILA-c1ass I an tigens but n ot in the I-ILA-c1ass Tl 
all e les that were inh erited by he r siblin gs (Cw5-1344-DRB 'I "' J 50 ·1-
DQA l "' 01 02-DQB I *(602). Two of the lIn aftccted children had a 
minim ally « I % body surface) aftected child (gen e ration IV) both 
EI-l-57 .1 - . N eithe r o f th ese grandchildren shared any HLA haplo-
type w ith their affec ted grand farhe r o r aun t. 
In famil y C . th e EI-I-57 .1 - grandf.1 the r w ho had a f.1 mily history 
o f pso riasis was no t affected and the El-l-57 .1 + gra ndm other w ho 
had a lll;gati ve f.l lllil y history (12 siblings , 23 nieces and nephews) 
was also not aftccted . All of their five children were affected. Four 
of them were ava ilable for in vestigation . They were I-I LA-identica l, 
sharing their mother 's EH-57. 1 and their f;lthe r' s haplotype. T he 
two 57 .1 + children (generation IV) . however. of one of the 
m onozygotic twins (confirmed by addition al markers o n chro m o-
som e 1. 7, and 12; p ;::: 99.996%) who inherited di ffe rent hapl otypes 
fi·om their father were borh aftccred, without shari ng any I-ILA 
haplotype with their grand father. 
D ISCUSSION 
O ur findings demonstrate that the Ca ucasian extended hap lotype 
57. 1: Cw6-B57-DRB1 "0701-DQAl *0201-DQB1 *0303 is highly 
signifi cantly overrepresented in type I psoriatics (p,.",. = 0.00021). 
and that EI-I-57 .1 + indi vidu als have a 26 times higher risk of 
develo ping type I psoriasis compared with indiv iduals w ho ar c 
EI-I-S7. 1 - (Fig 1) . T hese resu lts arc supported by a pedigree 
ana lysis of three multipl y affected fa milies with a tota l of14 cases of 
plaque psoriasis. In these fa milies no individu al was m arkedly 
aftccted (> 1 % body surface) in the absence of EH -57. 1. 
T he RJt associated with possess ion of the class II all e les of 
EH-57. 1 (DRB1 *0701, DQA"I *0201 and DQDl *0303) was con-
siderably lower than that associated w ith the class I an tigens (BS 7 
and Cw6) (Fig 1) . To examine the poss ibili ty that H LA class II 
m o lecul es of EH-57. 1 do not co ntribute directly to disease suscep-
tib ili ty but arc onl y overreprese nted du e to their linkage disequi-
librium with HLA Cw6-B57. the RJt confe rred by the class I and 
class II sides of this EH was ana lyzed separate ly (Fig 2). Individuals 
positive fo r the class I all eles ofEH-57.1 (Cw6-1357) but lacking th e 
class n alleles (DRJ31 *0701-DQA 1 *020 I-DQ13 I *0303) were sig-
nifi ca ntly overrepresen ted in type I pso ria tics compared w ith 
contro ls ("12% vs 2%; p = 0.OU60) and consequen tly ca rried a 6.3 
times elevated re la tive risk . In o n trast , individu als positive for the 
class II alleles of EI-I-5 7. 1 and negative for the [-I LA-class I all e les 
represen ted 5% of the contro l group but werc not found in the type 
I psoriasis g roup (p = 0.0265) and ca rried a reduced risk of 
developing typc I psoriasis (RJt = (U 5). T his strongly suggests that 
the susceptibili ty gene(s) is located telomeric to I-I LA class II, i.e ., 
in the central MH C o r in H LA class L T h; s is also supported by our 
recentl y reported finding tha t type I psoriatics sbow no pal-ricular 
association with any HLA-DPAI ' . H LA- DPB I*. or TAP2 allele 
(Fakler et aI, 1994). 
Two I-ILA class I antigens , 1357 and Cw6. conferred a signifi-
cantl y e levated re lari ve ri sk of developin g rype I psori as is (Fig 1). 
Bo th controls and type I psoriatics that ca rried 1357 were also 
positive for Cw6 . I-I LA-Cw6, on the othe r hand. was associated 
with va rio ll s I-ILA-13 an tigens. In con tro ls Cw6 was predominantly 
associa ted with B 13. T he calculared re lative risk for Cw6-B57 
carriers of dcveloping type I psorias is WaS 26 .7 compared w ith on ly 
2.8 for Cw6-1313 carriers, strongly suggestin g Cw6-B57 to be a 
genetic m arker for [;lI11ilial psoria sis. It is poss ibl e tha t HLA-B57 
contributes d irectl y to this susceptibili ty. O r, alternarively, HLA-
13 57 is a marker lo r a suscepribili ty gene. T he culprit gene could 
also be a sub type ofCw6, preferentially associated w ith I-ILA-B57, 
o r a non-I-ILA gene coded in the central MH C . such as the coding 
regions fo r tumor necrosis f.lctor and complem cnt. H owever, if the 
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susceptibility gene is part of the central MHC, it should be more 
strongly associated with HLA-B 13 as with HLA-Cw6; however, 
the HLA-Cw6 aUele was even overrepresented in type r psodatics 
lacking HLA-B57 (61'Yo vs 21 0/,,; p = 0.00005) . 
In contrast to o ur findings, previous studies have described an 
increased relative risk associated with both HLA-B13 and BS7 in 
early onset psoriasis (Svejgaard et 01,1974; Brenner ct ai, 1978), but 
these investigations did not differentiate between familial and 
sporadic psoriasis . White et al (1972) found a psoriasis freq uency 
among close relatives ofHLA-B17 (=B57 or BS8)-positive patients 
of 16.3°;', compared with only 5.4% for HLA-B13 , and concluded 
that HLA-B57 is a useful genetic marker for detecting a subgroup 
of psoriatic patients characterized by a high rate of afl:ected rela-
tives. Our results support these findings by demonstrating a highly 
significant overrepresentation ofHLA-B57 in type I but not in type 
Il psoriatics (Fig 1). 
The expert /eelll/icat assistallce oj C. Eme is graujlllly ae/wow/edged. H' e ''' allk 
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